Dermapharm targets $1bn IPO before end of quarter

Reuters yesterday reported that the German group Dermapharm is planning an IPO as early as the end of the quarter. The offer will be worth approximately €1bn. Dermapharm was sold by its owner in 2016, but it was withdrawn since the offers received did not meet expectations. Analysts expect that the group led by the Beier family will soon announce good financial results (2017), with an EBITDA of approximately €100m.
(Source: Reuters)